JDD HighlightsJDD in the MediaThe Latest

JDD in the News: Chlorophyll for Clear Skin, Depression & Isotretinoin

By May 26, 2021July 15th, 2021No Comments

In The News

In the News

JDD Impact Factor and Influence

The Journal of Drugs in Dermatology is featured in two recent articles about the latest TikTok trend — chlorophyll.

More on Chlorophyll

The Journal of Drugs in Dermatology in the News 

Allison Sit

The Journal of Drugs in Dermatology is featured in two recent articles about the latest TikTok trend — chlorophyll. Users claim products that contain chlorophyllin – a water-soluble version of chlorophyll — clear the skin, reduce bloating and help with weight loss. Both articles, “Liquid Chlorophyll: What to Know Before Buying,” by NBC News, and “Should You Hop on the Chlorophyll Wellness Trend?” by L’Officiel address the nutritional benefits of chlorophyll and ways to consume more of it.

The articles both cite a 2015 JDD study, “Pilot Study of Topical Copper Chlorophyllin Complex in Subjects With Facial Acne and Large Pores,” by Thomas J. Stephens, PhD, John P. McCook, and Dr. James H. Herndon, Jr. The study found a topical formulation containing a liposomal dispersion of sodium copper chlorophyllin complex to be clinically effective and well tolerated for the treatment of mild to moderate acne and large, visible pores when used for 3 weeks.

Dermatology Times highlighted a JDD study in its article, “Depression, Distress Different Between Patients Treated with Isotretinoin and Oral Antibiotics.” The article cites a February 2021 study, “Differences in Depression and Distress Between Acne Patients on Isotretinoin vs Oral Antibiotics” by Dr. April Armstrong and researchers. The study analyzed acne patients’ responses to Patient Health Questionnaire 2 and the Kessler 6-Item Psychological Distress Scale. Researchers found acne patients on isotretinoin experienced fewer depressive symptoms and psychological distress compared to patients on oral antibiotics.

The Dermatology Digest also wrote about the JDD study on depression and isotretinoin in its April print edition. The publication also published briefs on two other 2021 JDD articles, “Laboratory Testing in Telogen Effluvium,” and “Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.”

You May Also Like

Journal of Drugs in Dermatology JDD Article about Pyoderma Gangrenosum Following Total Colectomy for Ulcerative Colitis

Pyoderma Gangrenosum Following Total Colectomy for Ulcerative Colitis

| Case Reports, Featured Articles, Latest News, Medical Derm | No Comments
Case Report: Peristomal Pyoderma Gangrenosum After Colectomy — A Clinical Reminder for Dermatologists This JDD Case Report dives into how a 55‑year‑old woman developed rapidly progressive, painful cribriform ulcers with…
Journal of Drugs in Dermatology JDD Article about Nourishing the Skin: A Review of Diet's Role in Hidradenitis Suppurativa

Nourishing the Skin: A Review of Diet’s Role in Hidradenitis Suppurativa

| Featured Articles, Hidradenitis Suppurativa, Latest News | No Comments
What patients eat matters in HS: pro‑inflammatory diets worsen disease; anti‑inflammatory patterns and targeted supplements may help This literature review synthesizes recent studies connecting dietary patterns with hidradenitis suppurativa severity.…
Journal of Drugs in Dermatology JDD Article about Management of Hailey-Hailey Disease With Ruxolitinib 1.5% Cream

Management of Hailey-Hailey Disease With Ruxolitinib 1.5% Cream

| Featured Articles, Latest News, Medical Derm | No Comments
Case report shows symptom improvement with 1.5% ruxolitinib cream after standard therapies failed A 72‑year‑old woman with refractory Benign Familial Pemphigus  (Hailey‑Hailey disease) experienced persistent flares despite conventional management with…

Leave a Reply